X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8260) 8260
Newsletter (94) 94
Magazine Article (39) 39
Book Chapter (21) 21
Newspaper Article (5) 5
Book / eBook (3) 3
Publication (3) 3
Book Review (2) 2
Dissertation (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7703) 7703
male (4469) 4469
female (4268) 4268
thrombolytic therapy (4005) 4005
middle aged (3661) 3661
aged (3491) 3491
thrombolytic therapy - adverse effects (2892) 2892
treatment outcome (2737) 2737
thrombolytic therapy - methods (1798) 1798
cardiac & cardiovascular systems (1777) 1777
risk factors (1724) 1724
fibrinolytic agents - therapeutic use (1687) 1687
peripheral vascular disease (1664) 1664
adult (1655) 1655
fibrinolytic agents - adverse effects (1608) 1608
thrombolysis (1577) 1577
time factors (1504) 1504
stroke (1449) 1449
myocardial infarction - drug therapy (1387) 1387
aged, 80 and over (1304) 1304
fibrinolytic agents - administration & dosage (1290) 1290
tissue plasminogen activator - adverse effects (1264) 1264
tissue plasminogen activator - therapeutic use (1249) 1249
retrospective studies (1212) 1212
clinical neurology (1130) 1130
stroke - drug therapy (1122) 1122
tissue plasminogen activator - administration & dosage (1022) 1022
mortality (1005) 1005
therapy (1003) 1003
care and treatment (965) 965
myocardial infarction - therapy (920) 920
surgery (815) 815
acute disease (734) 734
acute myocardial-infarction (730) 730
management (718) 718
thrombolytic drugs (713) 713
myocardial infarction - mortality (712) 712
prospective studies (711) 711
tissue-plasminogen activator (698) 698
thrombosis (697) 697
medicine, general & internal (691) 691
acute ischemic-stroke (673) 673
heart attack (667) 667
brain ischemia - drug therapy (655) 655
anticoagulants - therapeutic use (652) 652
drug therapy (616) 616
prognosis (613) 613
tissue plasminogen activator (607) 607
follow-up studies (601) 601
heart attacks (601) 601
ischemia (600) 600
risk assessment (589) 589
trial (584) 584
alteplase (568) 568
angioplasty (547) 547
health aspects (544) 544
thrombosis - drug therapy (537) 537
cardiology (532) 532
neurosciences (530) 530
electrocardiography (521) 521
risk (510) 510
hemorrhage - chemically induced (508) 508
myocardial infarction (500) 500
thrombosis - etiology (498) 498
hemorrhage (494) 494
hematology (484) 484
medicine & public health (481) 481
recurrence (475) 475
infusions, intravenous (474) 474
cardiovascular (465) 465
abridged index medicus (460) 460
animals (452) 452
anticoagulants (452) 452
stents (452) 452
research (451) 451
tomography, x-ray computed (444) 444
reperfusion (441) 441
streptokinase - therapeutic use (431) 431
analysis (423) 423
neurology (414) 414
randomized controlled trials as topic (414) 414
stroke - therapy (413) 413
angioplasty, balloon, coronary (408) 408
coronary angiography (408) 408
streptokinase (408) 408
anticoagulants - adverse effects (404) 404
cerebral hemorrhage - chemically induced (392) 392
platelet aggregation inhibitors - therapeutic use (392) 392
tissue-plasminogen-activator (392) 392
streptokinase - adverse effects (390) 390
drug therapy, combination (389) 389
heparin - therapeutic use (381) 381
usage (374) 374
combined modality therapy (370) 370
complications (365) 365
outcomes (364) 364
stroke - diagnosis (364) 364
percutaneous coronary intervention (361) 361
thrombectomy (361) 361
myocardial infarction - physiopathology (359) 359
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7882) 7882
German (215) 215
French (101) 101
Spanish (80) 80
Japanese (62) 62
Russian (48) 48
Chinese (36) 36
Italian (36) 36
Portuguese (25) 25
Swedish (19) 19
Danish (18) 18
Norwegian (18) 18
Polish (15) 15
Hungarian (14) 14
Czech (13) 13
Dutch (9) 9
Serbian (6) 6
Turkish (4) 4
Finnish (2) 2
Hebrew (2) 2
Lithuanian (2) 2
Croatian (1) 1
Persian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e601S - e636S
Objectives: This article provides recommendations on the use of antithrombotic therapy in patients with stroke or transient ischemic attack (TIA). Methods... 
HIGH-RISK PATIENTS | TISSUE-PLASMINOGEN ACTIVATOR | CEREBRAL VENOUS THROMBOSIS | PATENT FORAMEN OVALE | RESPIRATORY SYSTEM | LONG-TERM SURVIVAL | LOW-MOLECULAR-WEIGHT | DEEP-VEIN THROMBOSIS | ASPIRIN PLUS DIPYRIDAMOLE | NONVALVULAR ATRIAL-FIBRILLATION | EXTENDED-RELEASE DIPYRIDAMOLE | CRITICAL CARE MEDICINE | Recombinant Proteins - therapeutic use | United States | Humans | Heparin - therapeutic use | Tissue Plasminogen Activator - therapeutic use | Intracranial Thrombosis - prevention & control | Recombinant Proteins - adverse effects | Heparin - adverse effects | Tissue Plasminogen Activator - adverse effects | Dose-Response Relationship, Drug | Fibrinolytic Agents - adverse effects | Societies, Medical | Aspirin - adverse effects | Fibrinolytic Agents - therapeutic use | Ischemic Attack, Transient - etiology | Aspirin - therapeutic use | Intracranial Thrombosis - drug therapy | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Stroke - prevention & control | Ischemic Attack, Transient - drug therapy | Intermittent Pneumatic Compression Devices | Intracranial Thrombosis - blood | Combined Modality Therapy | Stroke - drug therapy | Evidence-Based Medicine | Stroke - blood | Intracranial Thrombosis - etiology | Thrombolytic Therapy | Ischemic Attack, Transient - blood | Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed | American College of Chest Physician Evidence-Based Clinical Practice Guidelines Online Only
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e576S - e600S
Background: Antithrombotic therapy in valvular disease is important to mitigate thromboembolism, but the hemorrhagic risk imposed must be considered. Methods... 
PROSTHETIC VALVE | LOW-DOSE ASPIRIN | MITRAL ANNULAR CALCIFICATION | PATENT FORAMEN OVALE | RESPIRATORY SYSTEM | MOLECULAR-WEIGHT HEPARIN | ORAL ANTICOAGULANT-THERAPY | CEREBRAL ISCHEMIC EVENTS | AORTIC-VALVE-REPLACEMENT | SPONTANEOUS ECHO-CONTRAST | LEFT ATRIAL THROMBUS | CRITICAL CARE MEDICINE | Heart Valve Diseases - blood | Mitral Valve | Thrombosis - complications | Ductus Arteriosus, Patent - drug therapy | Humans | Postoperative Complications - blood | Postoperative Complications - prevention & control | Stroke - complications | Hemorrhage - prevention & control | Rheumatic Heart Disease - blood | Fibrinolytic Agents - adverse effects | Vitamin K - antagonists & inhibitors | Societies, Medical | Ductus Arteriosus, Patent - blood | Thromboembolism - prevention & control | Aspirin - adverse effects | Heart Valve Diseases - complications | Fibrinolytic Agents - therapeutic use | Rheumatic Heart Disease - drug therapy | Rheumatic Heart Disease - complications | Aspirin - therapeutic use | Thromboembolism - drug therapy | Postoperative Complications - drug therapy | Thrombosis - blood | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Stroke - prevention & control | Catheterization | Heart Atria | Heart Valve Prosthesis | Risk Factors | Ductus Arteriosus, Patent - complications | Combined Modality Therapy | Evidence-Based Medicine | Stroke - blood | Thromboembolism - blood | Heart Valve Diseases - drug therapy | Thrombosis - drug therapy | Hemorrhage - chemically induced | Thrombolytic Therapy - adverse effects | Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed | American College of Chest Physician Evidence-Based Clinical Practice Guidelines Online Only
Journal Article
JACC. Cardiovascular interventions, ISSN 1936-8798, 08/2015, Volume 8, Issue 10, pp. 1382 - 1392
Objectives This study conducted a prospective, single-arm, multicenter trial to evaluate the safety and efficacy of ultrasound-facilitated, catheter-directed,... 
fibrinolysis | thrombolysis | catheter embolectomy | catheter thrombolysis | pulmonary embolism | right ventricular failure | PERCUTANEOUS MECHANICAL THROMBECTOMY | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | EFFICACY | HEMORRHAGE | THROMBOSIS | RISK | COMPUTED-TOMOGRAPHY | EMBOLECTOMY | OUTCOMES | THROMBOLYTIC THERAPY | Catheterization, Peripheral - instrumentation | Prospective Studies | United States | Humans | Middle Aged | Catheterization, Peripheral - mortality | Male | Tomography, X-Ray Computed | Hypertrophy, Right Ventricular - etiology | Equipment Design | Tissue Plasminogen Activator - adverse effects | Ultrasonic Therapy - mortality | Fibrinolytic Agents - adverse effects | Time Factors | Adult | Female | Thrombolytic Therapy - instrumentation | Ultrasonic Therapy - adverse effects | Catheterization, Peripheral - adverse effects | Severity of Illness Index | Pulmonary Embolism - complications | Acute Disease | Risk Factors | Tissue Plasminogen Activator - administration & dosage | Treatment Outcome | Thrombolytic Therapy - mortality | Pulmonary Embolism - mortality | Pulmonary Embolism - diagnosis | Vascular Access Devices | Pulmonary Embolism - drug therapy | Aged | Fibrinolytic Agents - administration & dosage | Hemorrhage - chemically induced | Ultrasonic Therapy - instrumentation | Thrombolytic Therapy - adverse effects | Hypertension, Pulmonary - etiology
Journal Article
Cochrane library, ISSN 1465-1858, 2014, Volume 2016, Issue 1, p. CD000213
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2013, Volume 368, Issue 15, pp. 1379 - 1387
Reperfusion strategies with fibrinolysis or primary PCI were compared in this trial involving patients with ST-segment elevation myocardial infarction (STEMI).... 
MORTALITY | SURVIVAL | MEDICINE, GENERAL & INTERNAL | PERCUTANEOUS CORONARY INTERVENTION | RANDOMIZED-TRIAL | DELAYS | REPERFUSION STRATEGY | Recurrence | Myocardial Infarction - mortality | Ticlopidine - therapeutic use | Humans | Middle Aged | Male | Tissue Plasminogen Activator - therapeutic use | Enoxaparin - therapeutic use | Enoxaparin - adverse effects | Tissue Plasminogen Activator - adverse effects | Angioplasty, Balloon, Coronary | Heart Failure - prevention & control | Fibrinolytic Agents - adverse effects | Myocardial Infarction - therapy | Fibrinolytic Agents - therapeutic use | Thrombolytic Therapy - methods | Ticlopidine - adverse effects | Electrocardiography | Female | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Time-to-Treatment | Intracranial Hemorrhages - etiology | Kaplan-Meier Estimate | Ticlopidine - analogs & derivatives | Coronary Angiography | Myocardial Infarction - drug therapy | Aged | Drugs | Dose-response relationship (Biochemistry) | Usage | Care and treatment | Angiography | Angioplasty | Patient outcomes | Product/Service Evaluations | Thrombolytic drugs | Heart attack | Dosage and administration | Diagnosis | Drug therapy | Myocardial infarction | Anticoagulants | Fibrin | Heart attacks | Medical imaging | Reperfusion | Clopidogrel | Congestive heart failure | Fibrinolysis | Bleeding
Journal Article